PharmaVoice’s daily newsletter delivers must-read insight and analysis for pharma leaders. Sign up today:

PharmaVoice and @BioPharmaDive are partnering to host a two-day live event — The Next Frontier of the Life Sciences — that will examine the top trends shaping the drug industry. Check out the multi-session agenda and register here:

PharmaVoice and @BioPharmaDive are partnering to host a two-day live event — The Next Frontier of the Life Sciences — that will examine the top trends shaping the drug industry. Check out the multi-session agenda and register here:

Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today:

Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today:

Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today:

Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today:

Taking your biotech global? Here’s how you can navigate cultural norms

After years of struggling to create a pharmaceutical birth control option for men, it might soon be time for the fellas to get their turn taking “the pill.” #ReproductiveHealth

Conversations around #burnout typically put the onus on employees to deal with it — get more sleep, eat well, etc. But @CMaslach, a leading burnout expert, says companies should instead target the workplace systems that lead to it. #Biotech

As experts wrestle with COVID-19’s lab leak versus animal market debate, here’s what experts say are the suspected #origins for some of the worst #viral outbreaks in the last century.

There's less than one month to go until nominations close for the 2023 #PharmaVoice100 class. Have you nominated an inspiring life science #leader in your life yet?

Join us on tomorrow for our Future of Ophthalmology live virtual event. We'll sit down with various pharma industry experts to discuss new technology, new innovations, patient access and more. Take a peek at the topics and save your seat:

Join us on March 8th for our Future of Ophthalmology live virtual event. We'll sit down with various pharma industry experts to discuss new technology, new innovations, patient access and more. Take a peek at the topics and save your seat:

Know an inspirational leader in the life sciences? Nominate them to be a 2023 PharmaVoice 100 by April 1!

We want your feedback! Let us know how our journalism brings value to your day and where we can improve in our annual reader survey.

.@VivekGRamaswamy Ramaswamy, the former CEO of @Roivant and face of the “anti-woke” business movement, is running for president. Here's a look at his pharma legacy and where he stands on the issues.

With FDA’s longtime neuro head Billy Dunn out, industry is reeling over how the agency’s new acting director, Teresa Buracchio, could handle upcoming approval decisions – including today's expected decision on @ReataPharma's Friedreich’s Ataxia treatment.

Know an inspirational leader in the life sciences? Nominate them for the 2023 PharmaVoice 100 by April 1.

Join us on March 8th for our Future of Ophthalmology live virtual event. We'll sit down with various pharma industry experts to discuss new technology, new innovations, patient access and more. Take a peek at the topics and save your seat: